HDMA announces new leadership
Board undergoes annual changover
At the Healthcare Distribution Management Assn.’s recent board meeting, the group announced the regular succession of its leadership. The new chairman is David Neu, president of AmerisourceBergen Drug Corp., succeeding David Moody, CEO of Mutual Wholesale Drug Co., who will continue to serve as a member of the HDMA Executive Committee. The other new appointment is Ted Scherr, CEO of Dakota Drug Co., as vice chairman.
Other directors are: Kenneth Couch (president, Smith Drug Company); Paul Julian (EVP, McKesson); Michael Kaufmann (CEO, Pharmaceutical Segment, Cardinal Health); Dale Smith (chairman, H. D. Smith) and John Gray, Ex Officio (president, HDMA).
“I want to thank David Moody for his exceptional leadership and commitment to the Association in his two years as our Chairman, and welcome Dave Neu and Ted Scherr to their new roles,” said HDMA president and CEO John Gray. “With a host of issues on the horizon, 2013 looks to be a busy year for our association, and I look forward to working closely with Dave and Ted, as well as the entire board, as we continue to advocate for safe and efficient supply chain solutions.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
